GrifolsGRFS +2.08%84 OCF Yield % is 23.77 as of Jun. 26, 2026, which is 420% above its 10-year median of 4.57. GuruFocus rates GRFS with a GF Score™ of 84/100 and a GF Value™ of $8.79 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Grifols ranks better than 92.24% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Grifols OCF Yield % Related Terms
Grifols OCF Yield % Historical Data
* Premium members only.
The historical data trend for Grifols's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Grifols's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grifols OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grifols's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Grifols's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grifols (GRFS) has a OCF Yield % of 23.77 as of Jun. 26, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Grifols and its competitors. This is 420% above median its historical median of 4.57. Over the past decade, Grifols' OCF Yield % has ranged from 1.93 to 24.26. According to the industry distribution chart, Grifols ranks #78 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 7.8%.
Is Grifols' OCF Yield % too high?
Grifols' current OCF Yield % of 23.77 is 420% above median its 10-year median of 4.57. Over the past 10 years, this metric has ranged from a low of 1.93 to a high of 24.26. The Drug Manufacturers industry median OCF Yield % is 3.57. Grifols' value of 23.77 is 565.8% above this industry median. Based on the distribution chart, Grifols ranks #78 out of 1005 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Grifols has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Grifols' OCF Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Grifols ranks #78 out of 1005 companies for OCF Yield %. This places Grifols in the top 8% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.57. Grifols' value of 23.77 is 565.8% above this benchmark. Historically, Grifols' own OCF Yield % has ranged from 1.93 to 24.26 over the past decade. While the company's 10-year median is 4.57 vs. the industry median of 3.57, Grifols has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.57, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grifols's current OCF Yield % of 23.77 is 565.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Grifols and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grifols's current OCF Yield % is 23.77, which is 420% above median its own 10-year median of 4.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grifols stock overvalued right now?
Based on GuruFocus' analysis, Grifols (GRFS) is currently considered Modestly Undervalued. The stock's GF Value™ is $8.79, compared to a current price of $7.36 — trading 16.3% below its estimated fair value. The current OCF Yield % is 23.77, which is 420% above median its 10-year median of 4.57 and 565.8% above the Drug Manufacturers industry median of 3.57. Grifols' overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Grifols (GRFS), the current OCF Yield % is 23.77 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grifols (GRFS) Overvalued in 2026?
Based on GuruFocus' analysis, Grifols stock appears to be undervalued.
The current stock price of $7.36 is trading 16.3% below its estimated GF Value™ of $8.79.
GuruFocus considers Grifols to be Modestly Undervalued.
Key valuation signals for GRFS:
OCF Yield %: 23.77 (420% above median its 10-year median of 4.57)
GF Value™: $8.79 vs. price of $7.36 (16.3% below fair value)
Industry Position: 565.8% above the Drug Manufacturers median (#78 of 1005)
No single metric tells the full story. See the GRFS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
84GF Score
Get the complete analysis for GRFS
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRFS has been successfully added to your 
